Step 6: preparation of intermediate 10-allyloxy-5-(3-methylsulfonyloxypropyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10f)
Using the procedure described in example 3 (step 12), 10-Allyloxy-5-(3-hydroxy-propyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10e) (218 mg, 0.70 mmol) was converted to 10-allyloxy-5-(3-methylsulfonyloxypropyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10f) (272 mg, 0.70 mmol, 100%) without further purification.